IL33 and neoplasm: The authors show that mast cells are more abundant than ILC2s in gastric tumors and secrete macrophage-chemoattractant colony-stimulating factor 2 (CSF2), CCL3, and IL-6 in response to activation by tumor-derived IL-33.